Minerva Neurosciences Inc (NAS:NERV)
$ 2.48 -0.04 (-1.59%) Market Cap: 17.34 Mil Enterprise Value: -17.20 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 37/100

Minerva Neurosciences Inc Annual Shareholders Meeting Transcript

Jun 11, 2021 / 12:00PM GMT
Release Date Price: $23.2 (-5.54%)
Operator

Good morning, and welcome to the 2021 Annual Stockholder Meeting for Minerva Neurosciences. I will now turn today's meeting over to Devin Smith.

Devin Whittemore Smith
Minerva Neurosciences, Inc. - Senior VP, General Counsel & Secretary

Good morning, everyone. My name is Devin Smith, and I'm the General Counsel and Corporate Secretary for Minerva Neurosciences. And it's my pleasure to welcome you to Minerva's 2021 Annual Meeting of Stockholders. You can view the rules of conduct and procedure for this meeting as well as Minerva's proxy statement and annual report for 2020 in the

(technical difficulty)

portal. It's now 08:00 am, and I call this meeting to order.

But before we proceed with the formal business of the meeting, I'd like to introduce the members of Minerva's Board of Directors. They are Remy Luthringer, Chief Executive Officer and Chairman of the Board; Bill Doyle, who is our Lead Independent Director; Hans Peter Hasler; Jan van Heek, Jeryl Hilleman, Dr. David Kupfer and Fouzia Laghrissi-Thode.

I would now

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot